AACR Primer: first virtual AACR meeting of year will include data from over 40 trials

Data from an allogeneic CAR T therapy, bispecific mAbs and new immuno-oncology combinations are some of the highlights expected at the first virtual meeting of the year for the American Association for Cancer Research.

Due to the COVID-19 pandemic, AACR has split its annual conference into two virtual meetings. The first starts Monday, with a smaller selection of clinical trial results, presentations and discussions being held over the two day meeting...